Hatch-Waxman: Positioning Your Company For Success Against Generic Challenges

This webinar has ended.


The structure of the Hatch-Waxman Act and the realities of the pharmaceutical marketplace make generic challenges to a successful pharmaceutical product all but inevitable. Early planning and strategy - starting from before the time of invention - can ensure that your company is best positioned to deal with those future challenges.

In this webinar, life sciences attorneys Chad Shear and Geoff Biegler discuss best practices at all phases of the drug development process that can lead to successful outcomes to generic challenges, including:

  • Project start to invention
  • Development and approval
  • Litigation

Click the link to download a copy of the webinar slides.

Presenters: Geoff Biegler, Chad Shear